Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
Melissa K OsbornDepartment of Medicine, Emory University School of Medicine, Atlanta, GA, USAAbstract: Telbivudine was recently approved for the treatment of chronic hepatitis B. Phase III studies indicated its antiviral potency with 6- to 6.5-log copies/mL reductions in hepatitis B DNA levels at ye...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Livre |
| Publié: |
Dove Medical Press,
2009-10-01T00:00:00Z.
|
| Sujets: | |
| Accès en ligne: | Connect to this object online. |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
| Cote: |
A1234.567 |
|---|---|
| Exemplaire 1 | Disponible |